CD8 T cell persistence in treated HIV infection

Current Opinion in HIV and AIDS

Volumn 9, Issue 5, 2014, Pages 500-505

  Mudd, Joseph C ^a   Lederman, Michael M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bystander T cell activation; CD8 lymphocytosis; HIV 1; morbidity; mortality

Indexed keywords

CD8+ T LYMPHOCYTE; CELL EXPANSION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; REVIEW; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS;

EID: 84906050022     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000086     Document Type: Review

References (75)

1. Brehm MA, Selin LK, Welsh RM. CD8 T cell responses to viral infections in sequence. Cell Microbiol 2004; 6:411-421. (Pubitemid 38488934)
2. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: Implications for vaccine development. Nat Rev Immunol 2002; 2:251-262. (Pubitemid 37323225)
3. Kaech SM, Wherry EJ. Heterogeneity and cell-fate decisions in effector and memory CD8\+ T cell differentiation during viral infection. Immunity 2007; 27:393-405. (Pubitemid 47418674)
4. Prlic M, Williams MA, Bevan MJ. Requirements for CD8 T-cell priming, memory generation and maintenance. Curr Opin Immunol 2007; 19:315-319. (Pubitemid 46687015)
5. Joshi NS, Kaech SM. Effector CD8 T cell development: A balancing act between memory cell potential and terminal differentiation. J Immunol 2008; 180:1309-1315.
6. Cui W, Kaech SM. Generation of effector CD8\+ T cells and their conversion to memory T cells. Immunol Rev 2010; 236:151-166.
7. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8\+ lymphocytes. Science 1999; 283: 857-860.
8. Kolowos W, Schmitt M, Herrman M, et al. Biased TCR repertoire in HIV-1-infected patients due to clonal expansion of HIV-1-reverse transcriptasespecific CTL clones. J Immunol 1999; 162:7525-7533. (Pubitemid 29277733)
9. Weiss L, Roux A, Garcia S, et al. Persistent expansion, in a human immunodeficiency virus-infected person, of V beta-restricted CD4\+CD8\+ T lymphocytes that express cytotoxicity-associated molecules and are committed to produce interferon-gamma and tumor necrosis factor-alpha. J Infect Dis 1998; 178:1158-1162. (Pubitemid 28452214)
10. Than S, Kharbanda M, Chitnis V, et al. Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children. J Immunol 1999; 162:3680-3686. (Pubitemid 29313624)
11. Margolick JB, Donnenberg AD, Munoz A, et al. Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: Stable CD3\+ and declining CD3-populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993; 6:153-161. (Pubitemid 23082869)
12. Papagno L, Spina CA, Marchant A, et al. Immune activation and CD8\+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004; 2:E20.
13. Serrano-Villar S, Gutierrez C, Vallejo A, et al. The CD4/CD8 ratio in HIVinfected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect 2013; 66:57-66.
14. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4\+ and CD8\+ T-cell responses: Relationship to viral load in untreated HIV infection. J Virol 2001; 75:11983-11991. (Pubitemid 33115870)
15. Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001; 193:169-180. (Pubitemid 32524449)
16. Rahman MA, Kingsley LA, Atchison RW, et al. Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. J Clin MicrobiolV 29 1991; 1215-1220.
17. Bastidas S, Graw F, Smith MZ, et al. CD8\+ T cells are activated in an antigenindependent manner in HIV-infected individuals. J Immunol 2014; 192:1732-1744.
18. Haas A, Rehr M, Graw F, et al. HIV-1 replication activates CD4\+ T cells with specificities for persistent herpes viruses. EMBO Mol Med 2010; 2:231-244.
19. Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 1998; 8:177-187. (Pubitemid 28123745)
20. Miller JD, van der Most RG, Akondy RS, et al. Human effector and memory CD8\+ T cell responses to smallpox and yellow fever vaccines. Immunity 2008; 28:710-722.
21. Leung V, Gillis J, Raboud J, et al. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. PLoS One 2013; 8:e77665.
22. Appay V, Papagno L, Spina CA, et al. Dynamics of T cell responses in HIV infection. J Immunol 2002; 168:3660-3666. (Pubitemid 34250438)
23. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-354. (Pubitemid 44435155)
24. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8\+T cells. Blood 2003; 101:2711-2720. (Pubitemid 36857634)
25. Larsen M, Sauce D, Deback C, et al. Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog 2011; 7:e1002328.
26. Bengsch B, Seigel B, Ruhl M, et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8\+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 2010; 6:e1000947.
27. Trautmann L, Janbazian L, Chomont N, et al. Upregulation of PD-1 expression on HIV-specific CD8\+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12:1198-1202. (Pubitemid 44527357)
28. Zhang JY, Zhang Z, Wang X, et al. PD-1 up-regulation is correlated with HIVspecific memory CD8\+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007; 109:4671-4678. (Pubitemid 46827757)
29. Peretz Y, He Z, Shi Y, et al. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLoS Pathog 2012; 8:e1002840.
30. Breton G, Chomont N, Takata H, et al. Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection. J Immunol 2013; 191:2194-2204.
31. Petrovas C, Casazza JP, Brenchley JM, et al.PD-1 is a regulator of virus-specific CD8\+ T cell survival in HIV infection. J Exp Med 2006; 203:2281-2292. (Pubitemid 44498363)
32. Khaitan A, Unutmaz D. Revisiting immune exhaustion during HIV infection. Curr HIV/AIDS Rep 2011; 8:4-11.
33. Dietze KK, Zelinskyy G, Liu J, et al. Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8\+ T cells and efficiently reduces chronic retroviral loads. PLoS Pathog 2013; 9:e1003798.
34. Derhovanessian E, Larbi A, Pawelec G. Biomarkers of human immunosenescence: Impact of Cytomegalovirus infection. Curr Opin Immunol 2009; 21:440-445.
35. Plunkett FJ, Franzese O, Finney HM, et al. The loss of telomerase activity in highly differentiated CD8\+CD28-CD27-T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol 2007; 178:7710-7719. (Pubitemid 46898042)
36. Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol 2011; 11:289-295.
37. Koch S, Larbi A, Derhovanessian E, et al. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing 2008; 5:6.
38. Bandres E, Merino J, Vazquez B, et al. The increase of IFN-gamma production through aging correlates with the expanded CD8\+highCD28-CD57\+ subpopulation. Clin Immunol 2000; 96:230-235.
39. Eylar EH, Lefranc CE, Yamamura Y, et al. HIV infection and aging: Enhanced Interferon-and Tumor Necrosis Factor-alpha production by the CD8\+ CD28-T subset. BMC Immunol 2001; 2:10.
40. Le Priol Y, Puthier D, Lecureuil C, et al. High cytotoxic and specific migratory potencies of senescent CD8\+ CD57\+ cells in HIV-infected and uninfected individuals. J Immunol 2006; 177:5145-5154. (Pubitemid 44527586)
41. Fann M, Chiu WK, Wood WH 3rd, et al. Gene expression characteristics of CD28null memory phenotype CD8\+ T cells and its implication in T-cell aging. Immunol Rev 2005; 205:190-206. (Pubitemid 40780186)
42. Cao JN, Gollapudi S, Sharman EH, et al. Age-related alterations of gene expression patterns in human CD8\+ T cells. Aging Cell 2010; 9:19-31.
43. Mollet L, Li TS, Samri A, et al. Dynamics of HIV-specific CD8\+ T lymphocytes with changes in viral load. The RESTIM and COMET Study Groups. J Immunol 2000; 165:1692-1704. (Pubitemid 30604609)
44. Lempicki RA, Kovacs JA, Baseler MW, et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4\+ and CD8\+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci USA 2000; 97:13778-13783.
45. Serrano-Villar S, Sainz T, Lee SA, et al. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8\+ T cell activation, and increased risk of non-aids morbidity and mortality. PLoS Pathog 2014; 10:e1004078.
46. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011; 53:1120-1126.
47. Hasse B, Ledergerber B, Furrer H, et al., Swiss HIV cohort study. Morbidity and aging in HIV-infected persons: The Swiss HIV cohort study. Clin Infect Dis 2011; 53:1130-1139.
48. Sandler NG, Sereti I. Can early therapy reduce inflammation? Curr Opin HIV AIDS 2014; 9:72-79.
49. Serrano-Villar S, Perez-Elias MJ, Dronda F, et al. Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio. PloS One 2014; 9:e85798.
50. Combadiere B, Faure S, Autran B, et al. The chemokine receptor CX3CR1 controls homing and antiviral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients. AIDS 2003; 17:1279-1290. (Pubitemid 36819842)
51. Hurley A, Smith M, Karpova T, et al. Enhanced effector function of CD8(\+) T cells fromhealthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1. J Infect Dis V 207 2013; 638-650.
52. Funderburg NT, Lederman MM. Coagulation and morbidity in treated HIV infection. Thromb Res 2014; 133 (Suppl 1):S21-S24.
53. Fletcher CV, Staskus K, Wietgrefe SW, et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci USA 2014; 111:2307-2312.
54. Casazza JP, Betts MR, Hill BJ, et al. Immunologic pressure within class I-restricted cognate human immunodeficiency virus epitopes during highly active antiretroviral therapy. J Virol 2005; 79:3653-3663. (Pubitemid 40327953)
55. Ogg GS, Jin X, Bonhoeffer S, et al. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol 1999; 73:797-800. (Pubitemid 28565430)
56. Stone SF, Price P, French MA. Cytomegalovirus (CMV)-specific CD8\+T cells in individuals with HIV infection: Correlation with protection from CMV disease. J Antimicrob Chemother 2006; 57:585-588.
57. Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013; 21:6-13.
58. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371. (Pubitemid 44924494)
59. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and themagnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199:1177-1185.
60. Mehandru S, Poles MA, Tenner-Racz K, et al. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med 2006; 3:e484.
61. Marchetti G, Bellistri GM, Borghi E, et al. Microbial translocation is associated with sustained failure in CD4\+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 2008; 22:2035-2038.
62. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272:1947-1950. (Pubitemid 26234507)
63. Kamath AT, Sheasby CE, Tough DF. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma. J Immunol 2005; 174:767-776. (Pubitemid 40094271)
64. Hardy GA, Sieg S, Rodriguez B, et al. Interferon-alpha is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. PLoS One 2013; 8:e56527.
65. Fernandez S, Tanaskovic S, Helbig K, et al. CD4\+ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4\+ T cells. J Infect Dis 2011; 204:1927-1935.
66. Becker TC, Wherry EJ, Boone D, et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002; 195:1541-1548. (Pubitemid 34666068)
67. Kurtulus S, Tripathi P, Moreno-Fernandez ME, et al. Bcl-2 allows effector and memory CD8\+ T cells to tolerate higher expression of Bim. J Immunol 2011; 186:5729-5737.
68. Lugli E, Goldman CK, Perera LP, et al. Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates. Blood 2010; 116:3238-3248.
69. Biancotto A, Grivel JC, Iglehart SJ, et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007; 109:4272-4279. (Pubitemid 46743393)
70. Shive CL, Mudd JC, Funderburg NT, et al. Inflammatory cytokines drive CD4\+ T-Cell cycling and impaired responsiveness to interleukin 7: Implications for immune failure in HIV disease. J Infect Dis 2014. [Epub ahead of print]
71. Doitsh G, Galloway NL, Geng X, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014; 505:509-514.
72. Condotta SA, Cabrera-Perez J, Badovinac VP, Griffith TS. T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression. Crit Rev Immunol 2013; 33:23-40.
73. Mackall CL, Fleisher TA, Brown MR, et al. Distinctions between CD8\+ and CD4\+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89:3700-3707. (Pubitemid 27227093)
74. Ribeiro RM, Mohri H, Ho DD, Perelson AS. In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4\+ but not CD8\+ T cells depleted? Proc Natl Acad Sci USA 2002; 99:15572-15577. (Pubitemid 35403975)
75. Lederman MM, Calabrese L, Funderburg NT, et al. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis 2011; 204:1217-1226.